Novel Pituitary Ligands: Peroxisome Proliferator Activating Receptor-γ

Author： Heaney Anthony P.  

Publisher： Springer Publishing Company

ISSN： 1386-341X

Source： Pituitary, Vol.6, Iss.3, 2003-01, pp. : 153-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator Activated Receptor-γ (PPAR-γ) Ligands and Angiogenesis

By Margeli A.   Kouraklis G.   Theocharis S.  

Angiogenesis, Vol. 6, Iss. 3, 2003-01 ,pp. : 165-169

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor γ as a Novel Therapeutic Target in Asthma

By Park Seoung Ju   Lee Yong Chul  

Journal of Asthma, Vol. 45, Iss. 1, 2008-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

By Borghi Claudio  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 3, 2006-01 ,pp. : 81-84

Adis International

Access to resources Recommend Favorite

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation to Reduce Cardiovascular Risk in Patients with Insulin Resistance

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 1, 2012-04 ,pp. : 33-41

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-γ Pro12Ala Polymorphism and Risk of Osteopenia in β-Thalassemia Major Patients

By Sahmani Mehdi   Gholami Abdollah   Azarkeivan Azita   Darabi Masoud   Ahmadi Mohammad Hossein   Sabet Majid Sirati   Najafipour Reza  

Hemoglobin, Vol. 37, Iss. 6, 2013-12 ,pp. : 564-573

Informa Healthcare

Access to resources Recommend Favorite